[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$imrxs](/topic/$imrxs) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "JSYK: As the Story goes the first investors in Neil Kumar's $BBIO was one of $IMRX's Directors Peter Feinberg and Seth Merrin (no relation to IMRX - as far as I know). Neil Kumar Ph.D. wasn't having much luck attracting investors until these two came along then all of a sudden Kohlberg Kravis Roberts (KKR) and soon after Perceptive Advisors came in. Anyway IMRX's Director Peter Feinberg on 9/29 and 9/30 added to his position as he has been adding for the past two years. Here is Peter Feinberg's purchases w/ his direct and indirect holdings that was filed on 9/30 for 9/29: And here is his most" [X Link](https://x.com/Quantumup1/status/1974177818981327085) [@Quantumup1](/creator/x/Quantumup1) 2025-10-03T18:20Z 3845 followers, 14.2K engagements "Oppenheimer raised $IMRX's PT to $XX from $XX reiterated at an Outperform and said: Good things come in threes as IMRX surprised with an earlier-than-expected update on atebimetinib in 1L PDAC. $SNY $RVMD Oppenheimer added: The sooner the better when data are this strong exceeding expectations that we had recently laid out: 1) Encouragingly the 9-month OS rate a key focus of the update achieved XX% well above our XX% expectation and clearly separated from historical GnP benchmarks. 2) The favorable OS outcome was further supported by an impressive XX% PFS rate at X months which altogether" [X Link](https://x.com/Quantumup1/status/1971221697110982964) [@Quantumup1](/creator/x/Quantumup1) 2025-09-25T14:34Z 3844 followers, 2640 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"JSYK: As the Story goes the first investors in Neil Kumar's $BBIO was one of $IMRX's Directors Peter Feinberg and Seth Merrin (no relation to IMRX - as far as I know). Neil Kumar Ph.D. wasn't having much luck attracting investors until these two came along then all of a sudden Kohlberg Kravis Roberts (KKR) and soon after Perceptive Advisors came in. Anyway IMRX's Director Peter Feinberg on 9/29 and 9/30 added to his position as he has been adding for the past two years. Here is Peter Feinberg's purchases w/ his direct and indirect holdings that was filed on 9/30 for 9/29: And here is his most"
X Link @Quantumup1 2025-10-03T18:20Z 3845 followers, 14.2K engagements
"Oppenheimer raised $IMRX's PT to $XX from $XX reiterated at an Outperform and said: Good things come in threes as IMRX surprised with an earlier-than-expected update on atebimetinib in 1L PDAC. $SNY $RVMD Oppenheimer added: The sooner the better when data are this strong exceeding expectations that we had recently laid out: 1) Encouragingly the 9-month OS rate a key focus of the update achieved XX% well above our XX% expectation and clearly separated from historical GnP benchmarks. 2) The favorable OS outcome was further supported by an impressive XX% PFS rate at X months which altogether"
X Link @Quantumup1 2025-09-25T14:34Z 3844 followers, 2640 engagements
/topic/$imrxs/posts